Skip to main content
Syncona Limited logo

Syncona Limited — Investor Relations & Filings

Ticker · SYNC ISIN · GG00B8P59C08 LEI · 213800X8MBI5VQITLW60 IL Financial and insurance activities
Open in API
Filings indexed 1,030 across all filing types
Latest filing 2024-10-18 Transaction in Own Shar…
Country GG Guernsey
Listing IL SYNC

About Syncona Limited

https://www.synconaltd.com/

Syncona Limited is a life science investment company focused on founding, building, and funding a portfolio of healthcare businesses. The company's strategy is to identify and advance exceptional science to create globally leading companies capable of delivering transformational treatments to patients, particularly in areas with high unmet medical needs. Its portfolio is concentrated in innovative therapeutic areas, including gene therapy, cell therapy, and biologics. Syncona actively manages its companies to reach key value inflection points, aiming to generate significant long-term capital appreciation for shareholders through strategic events such as mergers, acquisitions, and other liquidity events.

Recent filings

Filing Released Lang Actions
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' by Syncona Limited, detailing the date of purchase, the aggregate number of shares purchased (75,000), and the price paid. It also updates the total voting rights following the treasury share acquisition. This directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category (POS). The presence of the RNS Number and the closing statement about RNS being the news service of the London Stock Exchange confirms it is a regulatory announcement, but the specific content dictates the 'POS' classification over the general 'RNS' fallback.
2024-10-18 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' where the company purchased 130,000 of its ordinary shares as part of a previously announced share buyback programme. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document is short and structured like a regulatory notification, confirming the specific nature of the transaction rather than being a comprehensive report or a general announcement of a report.
2024-10-17 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' where the company purchased 130,000 ordinary shares as part of its share buyback programme. It details the date, volume, and price of the transaction, and updates the total voting rights. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The presence of the RNS Number and the closing statement referencing RNS as the Primary Information Provider confirms it is a regulatory announcement, but the specific content dictates the POS classification over the general RNS fallback.
2024-10-16 English
Beacon announces positive data from Phase II trial
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 2881I' and contains standard regulatory boilerplate language from the London Stock Exchange's RNS service, indicating it is a regulatory announcement. The content details positive clinical trial data (Phase II SKYLINE trial) for a portfolio company (Beacon Therapeutics) of the reporting entity (Syncona Limited). This type of announcement, which disseminates material, non-public information to the market via an official channel (RNS), is best classified as a general Regulatory Filing (RNS), as it is not a full financial report (10-K, IR), an earnings release (ER), or a specific management/board change (MANG). It is an announcement of clinical progress, which falls under the broad regulatory disclosure category.
2024-10-15 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' where the company purchased 130,000 of its ordinary shares as part of a previously announced share buyback programme. It details the date, volume, and price of the transactions. This directly corresponds to the definition of 'Transaction in Own Shares' (Code: POS). The document is short and appears to be a regulatory disclosure via RNS, but the core subject matter is the share repurchase, making POS the most specific classification.
2024-10-15 English
Transaction in Own Shares
Transaction in Own Shares Classification · 1% confidence The document explicitly announces a 'Transaction in Own Shares' by Syncona Limited, detailing the date of purchase, the aggregate number of shares purchased (130,000), and the prices paid. It also updates the total voting rights following the transaction. This content directly corresponds to the definition of a report detailing the company buying back or selling its own shares. Therefore, the appropriate filing type is 'Transaction in Own Shares' (POS). The presence of the RNS Number and the closing statement referencing RNS as the Primary Information Provider confirms it is a regulatory announcement, but the specific subject matter dictates the POS code over the general RNS code.
2024-10-14 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.